These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27801526)

  • 21. 3D Echocardiography - A Useful Method for Cardiovascular Risk Assessment in End-Stage Renal Disease Patients.
    Kovářová M; Žilinská Z; Páleš J; Kužmová Z; Gažová A; Smaha J; Kužma M; Jackuliak P; Štvrtinová V; Kyselovič J; Payer J
    Physiol Res; 2021 Nov; 70(Suppl 1):S109-S120. PubMed ID: 35503056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fibroblast growth factor-23 and Vitamin D emerge as nontraditional risk factors and may affect cardiovascular risk.
    Masson S; Agabiti N; Vago T; Miceli M; Mayer F; Letizia T; Wienhues-Thelen U; Mureddu GF; Davoli M; Boccanelli A; Latini R;
    J Intern Med; 2015 Mar; 277(3):318-330. PubMed ID: 24620922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
    Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
    Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor-23 and cardiac structure and function.
    Agarwal I; Ide N; Ix JH; Kestenbaum B; Lanske B; Schiller NB; Whooley MA; Mukamal KJ
    J Am Heart Assoc; 2014 Feb; 3(1):e000584. PubMed ID: 24525546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Structure and Function and Subsequent Kidney Disease Progression in Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Ishigami J; Kansal M; Mehta R; Srivastava A; Rahman M; Dobre M; Al-Kindi SG; Go AS; Navaneethan SD; Chen J; He J; Bhat ZY; Jaar BG; Appel LJ; Matsushita K;
    Am J Kidney Dis; 2023 Aug; 82(2):225-236. PubMed ID: 36935072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of Left Ventricular Characteristics Assessed by Cardiac Magnetic Resonance Imaging and Cardiovascular Biomarkers Related to Kidney Transplantation.
    Prasad GVR; Yan AT; Nash MM; Kim SJ; Wald R; Wald R; Lok C; Gunaratnam L; Karur GR; Kirpalani A; Connelly PW
    Can J Kidney Health Dis; 2018; 5():2054358118809974. PubMed ID: 30542623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation.
    Baia LC; Humalda JK; Vervloet MG; Navis G; Bakker SJ; de Borst MH;
    Clin J Am Soc Nephrol; 2013 Nov; 8(11):1968-78. PubMed ID: 23929933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of left atrial remodeling in kidney transplant patients using cardiac magnetic resonance imaging.
    Huang F; Connelly PW; Prasad GVR; Nash MM; Gunaratnam L; Deva DP; Lok CE; Yuan W; Wald RM; Shalmon T; Wald R; Connelly KA; Yan AT
    J Nephrol; 2021 Jun; 34(3):851-859. PubMed ID: 32910428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.
    Roy C; Lejeune S; Slimani A; de Meester C; Ahn As SA; Rousseau MF; Mihaela A; Ginion A; Ferracin B; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Horman S; Gruson D; Gerber BL; Pouleur AC
    ESC Heart Fail; 2020 Oct; 7(5):2494-2507. PubMed ID: 32578967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA.
    Almahmoud MF; Soliman EZ; Bertoni AG; Kestenbaum B; Katz R; Lima JAC; Ouyang P; Miller PE; Michos ED; Herrington DM
    J Am Heart Assoc; 2018 Sep; 7(18):e008334. PubMed ID: 30371180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-transplantation Anemia Predicts Cardiovascular Morbidity and Poor Graft Function in Kidney Transplant Recipients.
    Gurlek Demirci B; Sezer S; Sayin CB; Tutal E; Uyar ME; Ozdemir Acar FN; Haberal M
    Transplant Proc; 2015 May; 47(4):1178-81. PubMed ID: 26036548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
    Bhan I; Shah A; Holmes J; Isakova T; Gutierrez O; Burnett SM; Jüppner H; Wolf M
    Kidney Int; 2006 Oct; 70(8):1486-94. PubMed ID: 16941023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and predictors of early cardiovascular events after kidney transplantation: evaluation of pre-transplant cardiovascular work-up.
    Delville M; Sabbah L; Girard D; Elie C; Manceau S; Piketty M; Martinez F; Méjean A; Legendre C; Sberro-Soussan R
    PLoS One; 2015; 10(6):e0131237. PubMed ID: 26107641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of gender on echocardiographic characteristics in heart transplant recipients.
    Ingvarsson A; Werther-Evaldsson A; Smith GJ; Waktare J; Nilsson J; Stagmo M; Roijer A; Rådegran G; Meurling C
    Clin Physiol Funct Imaging; 2019 Jul; 39(4):246-254. PubMed ID: 30770630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The atrial uremic cardiomyopathy regression in patients after kidney transplantation - the prospective echocardiographic study.
    Zapolski T; Furmaga J; Wysokiński AP; Wysocka A; Rudzki S; Jaroszyński A
    BMC Nephrol; 2019 May; 20(1):152. PubMed ID: 31046698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-Transplant Hypophosphatemia and the Risk of Death-Censored Graft Failure and Mortality after Kidney Transplantation.
    van Londen M; Aarts BM; Deetman PE; van der Weijden J; Eisenga MF; Navis G; Bakker SJL; de Borst MH;
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1301-1310. PubMed ID: 28546442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Global Longitudinal Strain in Renal Transplant Recipients and Immunosuppressive Regimen.
    Obremska M; Szymczak M; Letachowicz K; Zyśko D; Boratyńska M; Łukaszewski M; Krajewska M
    Transplant Proc; 2020 Oct; 52(8):2310-2314. PubMed ID: 32446693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients.
    Barros X; Torregrosa JV; Martínez de Osaba MJ; Casals G; Paschoalin R; Durán CE; Campistol JM
    Transplantation; 2012 Oct; 94(8):830-6. PubMed ID: 23018879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of cardiovascular diseases in kidney transplant recipients and its relationship with asymmetric dimethylarginine, fibroblast growth factor-23 and multiple inflammatory markers.
    Wołoszyk-Chojecka P; Malgorzewicz S; Chamienia A; Puchalska-Reglińska E; Dębska-Ślizień A
    Acta Biochim Pol; 2022 Nov; 69(4):847-854. PubMed ID: 36346961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue Doppler Imaging and Intima-Media Thickness as Noninvasive Methods of Cardiovascular Risk Stratification in Patients After Kidney Transplantation.
    Dudziak M; Rawicz-Zegrzda D; Jankowska M; Dębska-Ślizień A; Wołyniec Z; Rutkowski B
    Transplant Proc; 2016 Jun; 48(5):1535-8. PubMed ID: 27496442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.